# Human Umbilical Cord Mesenchymal Stem Cell(UC-MSC)Delayed Renal Chronic Kidney Disease(CKD3、4 )

> **NCT05512988** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 44 (estimated)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **BIOLOGICAL:** UC-MSC
- **BIOLOGICAL:** Saline solution

## Key facts

- **NCT ID:** NCT05512988
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-13
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-05-31
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2022-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05512988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05512988, "Human Umbilical Cord Mesenchymal Stem Cell(UC-MSC)Delayed Renal Chronic Kidney Disease(CKD3、4 )". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05512988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
